IP Library › Assignment 035576/0278
Patent Assignment
Reel/Frame 035576/0278

Assignment of Assignor's Interest

Recorded: 2015-05-06 Pages: 19
Assignor
MERCK SHARP & DOHME CORP.
Executed: 2014-03-24
Assignee
SIRNA THERAPEUTICS, INC.
300 THIRD STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties (3)
Rna Interference Mediated Inhibition of Hypoxia Inducible Factor 1 (HIF1) Gene Expression Using Short Interfering Nucleic Acid (Sina)
Patent: 7,795,422 →
Application: 12/175,367 →
Publication: US 2009/0192104
Rna Interference Mediated Inhibition of Cyclin D1 Gene Expression Using Short Interfering Nucleic Acid (Sina)
Patent: 8,067,575 →
Application: 12/200,736 →
Publication: US 2009/0137512
Rna Interference Mediated Inhibition of Platelet-Derived Endothelial Cell Growth Factor (ECGF1) Gene Expression Using Short Interfering Nucleic Acid (Sina)
Patent: 7,678,897 →
Application: 12/204,572 →
Publication: US 2009/0105178
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
Change of Name Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
Security Interest Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →